47 / 103
P
eripheral
polyneuropathy
in
severely
obese
patients
with
metabolic
syndrome
but
without
diabetes
: A
ssociation
with
low
HDL-
cholesterol
R
ev
A
ssoc
M
ed
B
ras
2017; 63(4):324-331
331
20.
Ziegler D, Rathmann W, Meisinger C, Dickhaus T, Mielck A; KORA Study
Group. Prevalence and risk factors of neuropathic pain in survivors of
myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial
Infarction Registry. Eur J Pain. 2009; 13(6):582-7.
21.
Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, et al.
Low HDL cholesterol is associated with the risk of stroke in elderly diabetic
individuals: changes in the risk for atherosclerotic diseases at various ages.
Diabetes Care. 2009; 32(7):1221-3.
22.
Reiner Z, Muacevi
ć
-Katanec D, Katanec D, Tedeschi-Reiner E. [Low HDL-
-cholesterol – an important risk factor for cardiovascular diseases]. Lijec
Vjesn. 2011; 133(3-4):111-6.
23.
Blazek A, Rutsky J, Osei K, Maiseyeu A, Rajagopalan S. Exercise-mediated
changes in high-density lipoprotein: impact on form and function. Am
Heart J. 2013; 166(3):392-400.
24.
Eftekhari E, Zafari A, Gholami M. Physical activity, lipid profiles and leptin.
J Sport Med Phys Fitness. 2016; 56(4):465-9.
25. Cesa CC, Barbiero SM, Petkowicz RO, Martins CC, Marques RD, Andreolla
AA, et al. Effectiveness of physical exercise to reduce cardiovascular risk factors
in youths: a randomized clinical trial. J Clin Med Res. 2015; 7(5):348-55.
26.
Schmid H, Goelzer Neto C, Dias L, Weston A, Espíndola M, Pioner S, et al.
Metabolic syndrome resolution by Roux-en-Y gastric bypass in a real world:
a case control study. Rev Assoc Med Bras. 2015; 61(2):161-9.
27. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJB. A
controlled study of peripheral neuropathy after bariatric surgery. Neurology.
2004; 63(8):1462-70.
28.
Scanu AM, Edelstein C. HDL: bridging past and present with a look at the
future. FASEB J. 2008; 22(12):4044-54.
29.
Mahdy Ali K, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk
reduction by raising HDL cholesterol – current therapies and future
opportunities. Br J Pharmacol. 2012; 167(6):1177-94.
30. Assmann G, Gotto AM. HDL cholesterol and protective factors in
atherosclerosis. Circulation. 2004; 109(1):III8-14.
31.
Posse de Chaves EI, Vance DE, Campenot RB, Kiss RS, Vance JE. Uptake of
lipoproteins for axonal growth of sympathetic neurons. J Biol Chem. 2000;
275(26):19883-90.
32.
Rodrigues B, Santana AA, Santamarina AB, Oyama LM, Caperuto EC, de
Souza CT, et al. Role of training and detraining on inflammatory and
metabolic profile in infarcted rats: influences of cardiovascular autonomic
nervous system. Mediators Inflamm. 2014; 2014:207131.
33. Grans CF, Feriani DJ, Abssamra MEV, Rocha LY, Carrozzi NM, Mostarda
C, et al. Resistance training after myocardial infarction in rats: Its role on
cardiac and autonomic function. Arq Bras Cardiol. 2014; 103(1):60-8.
34.
Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, et al.
Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;
29(6):1294-9.
35.
Singleton JR, Marcus RL, Lessard MK, Jackson JE, Smith AG. Supervised
exercise improves cutaneous reinnervation capacity in metabolic syndrome
patients. Ann Neurol. 2015; 77(1):146-53.